Currently out of the existing stock ratings of Thomas Stephan, 18 are a HOLD (34.62%), 34 are a BUY (65.38%).

Thomas Stephan

Work Performance Price Targets & Ratings Chart

Analyst Thomas Stephan, currently employed at STIFEL, carries an average stock price target met ratio of 61.02% that have a potential upside of 16.99% achieved within 65 days.

Thomas Stephan’s has documented 107 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GKOS, Glaukos Corp at 17-Jul-2026.

Wall Street Analyst Thomas Stephan

Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for RXST (RXSIGHT) at 12/12/2023. The price target of $40 was fulfilled within 2 days with a profit of $2.47 (6.58%) receiving and performance score of 32.91.

Average potential price target upside

of $20.21 (23.39%) on GKOS (GLAUKOS CORP).
of $5.46 (5.79%) on TMDX (TRANSMEDICS GROUP).
of $5.02 (10.03%) on RXST (RXSIGHT).

GKOS Glaukos Corp SGHT Sight Sciences STAA STAAR Surgical Company RXST Rxsight ALC Alcon AG BLCO Bausch + Lomb Corp TMDX TransMedics Group ATEC Alphatec Holdings OFIX Orthofix Medical IRIX IRIDEX

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Thomas Stephan (STIFEL)